TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

BACKGROUND: About 20% of resectable oesophageal carcinoma is resistant to preoperative chemoradiotherapy. Here we hypothesised that the expression of the antiapoptotic gene Baculoviral inhibitor of apoptosis repeat containing (BIRC)3 induced by the transforming growth factor β activated kinase 1 (TA...

詳細記述

保存先:
書誌詳細
出版年:Br J Cancer
主要な著者: Piro, G, Giacopuzzi, S, Bencivenga, M, Carbone, C, Verlato, G, Frizziero, M, Zanotto, M, Mina, M M, Merz, V, Santoro, R, Zanoni, A, De Manzoni, G, Tortora, G, Melisi, D
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2015
主題:
Translational Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578082/
https://ncbi.nlm.nih.gov/pubmed/26291056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.283
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料